Literature DB >> 17335688

Myeloid growth factors. Clinical practice guidelines in oncology.

Jeffrey Crawford, Betsy Althaus, James Armitage, Lodovico Balducci, Charles Bennett, Douglas W Blayney, Spero R Cataland, David C Dale, George D Demetri, Harry P Erba, James Foran, Alison G Freifeld, Mark L Heaney, Sally Htoy, Dwight D Kloth, Gary H Lyman, Wells A Messersmith, Laura Boehnke Michaud, Sarah C Miyata, Amy Robbins, Martin S Tallman, Saroj Vadhan-Raj, Peter Westervelt, Michael K Wong.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17335688     DOI： 10.6004/jnccn.2007.0019

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  13 in total

1.  Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.

Authors:  Arnold L Potosky; Jennifer L Malin; Benjamin Kim; Elizabeth A Chrischilles; Jane C Weeks
Journal:  J Natl Cancer Inst       Date:  2011-10-28       Impact factor: 13.506

Review 2.  [Comorbidity oriented oncology - an overview].

Authors:  Ralph Simanek; Michael Wuensch; Roland Edlinger; Bernhard Hammerl-Ferrari; Ludwig Kramer; Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

3.  Prognostic significance of neutropenia during adjuvant concurrent chemoradiotherapy in early cervical cancer.

Authors:  Yun Hwan Kim; Hyun Hoon Chung; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

4.  Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes.

Authors:  Arnold L Potosky; Jennifer L Malin; Benjamin Kim; Elizabeth A Chrischilles; Solomon B Makgoeng; Nadia Howlader; Jane C Weeks
Journal:  J Natl Cancer Inst       Date:  2011-06-13       Impact factor: 13.506

5.  Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor.

Authors:  Ruth Pettengell; Peter Bias; Udo Mueller; Nicole Lang
Journal:  Support Care Cancer       Date:  2016-01-16       Impact factor: 3.603

6.  Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients.

Authors:  Alfredo Carrato; Luis Paz-Ares Rodríguez; Alvaro Rodríguez Lescure; Ana M Casas Fernández de Tejerina; Eduardo Díaz Rubio García; Pedro Pérez Segura; Manuel Constenla Figueiras; Rocío García Carbonero; José Gómez Codina; Ana Lluch Hernández; José Pablo Maroto Rey; Miguel Martín Jiménez; José Ignacio Mayordomo Cámara; José Andrés Moreno Nogueira; Antonio Rueda Domínguez
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

7.  Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study.

Authors:  B Linot; P Augereau; R Breheret; L Laccourreye; O Capitain
Journal:  Support Care Cancer       Date:  2014-05-13       Impact factor: 3.603

Review 8.  Advances in the treatment of neutropenia.

Authors:  David C Dale
Journal:  Curr Opin Support Palliat Care       Date:  2009-09       Impact factor: 2.302

9.  Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial.

Authors:  Weidong Lu; Ursula A Matulonis; Anne Doherty-Gilman; Hang Lee; Elizabeth Dean-Clower; Andrew Rosulek; Carolyn Gibson; Annekathryn Goodman; Roger B Davis; Julie E Buring; Peter M Wayne; David S Rosenthal; Richard T Penson
Journal:  J Altern Complement Med       Date:  2009-07       Impact factor: 2.579

10.  Characterization and lymphocyte proliferation activity of an oligosaccharide degraded from Astragalus polysaccharide.

Authors:  Zhen-Yuan Zhu; Jin-Yu Zhang; Fei Liu; Ling Chen; Li-Jing Chen; Yun Tang
Journal:  Medchemcomm       Date:  2017-06-14       Impact factor: 3.597
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.